2etl

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="2etl" size="450" color="white" frame="true" align="right" spinBox="true" caption="2etl, resolution 2.400&Aring;" /> '''Crystal Structure ...)
Line 1: Line 1:
-
[[Image:2etl.gif|left|200px]]<br />
+
[[Image:2etl.gif|left|200px]]<br /><applet load="2etl" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="2etl" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="2etl, resolution 2.400&Aring;" />
caption="2etl, resolution 2.400&Aring;" />
'''Crystal Structure of Ubiquitin Carboxy-terminal Hydrolase L1 (UCH-L1)'''<br />
'''Crystal Structure of Ubiquitin Carboxy-terminal Hydrolase L1 (UCH-L1)'''<br />
==Overview==
==Overview==
-
The ubiquitin C-terminal hydrolase UCH-L1 (PGP9.5) comprises &gt;1% of total, brain protein but is almost absent from other tissues [Wilkinson, K. D., et al. (1989) Science 246, 670-673]. Mutations in the UCH-L1 gene have, been reported to be linked to susceptibility to and protection from, Parkinson's disease [Leroy, E., et al. (1998) Nature 395, 451-452;, Maraganore, D. M., et al. (1999) Neurology 53, 1858-1860]. Abnormal, overexpression of UCH-L1 has been shown to correlate with several forms of, cancer [Hibi, K., et al. (1998) Cancer Res. 58, 5690-5694]. Because the, amino acid sequence of UCH-L1 is similar to that of other ubiquitin, C-terminal hydrolases, including the ubiquitously expressed UCH-L3, which, appear to be unconnected to neurodegenerative disease, the structure of, UCH-L1 and the effects of disease associated mutations on the structure, and function are of considerable importance. We have determined the, three-dimensional structure of human UCH-L1 at 2.4-A resolution by x-ray, crystallography. The overall fold resembles that of other ubiquitin, hydrolases, including UCH-L3, but there are a number of significant, differences. In particular, the geometry of the catalytic residues in the, active site of UCH-L1 is distorted in such a way that the hydrolytic, activity would appear to be impossible without substrate induced, conformational rearrangements.
+
The ubiquitin C-terminal hydrolase UCH-L1 (PGP9.5) comprises &gt;1% of total brain protein but is almost absent from other tissues [Wilkinson, K. D., et al. (1989) Science 246, 670-673]. Mutations in the UCH-L1 gene have been reported to be linked to susceptibility to and protection from Parkinson's disease [Leroy, E., et al. (1998) Nature 395, 451-452; Maraganore, D. M., et al. (1999) Neurology 53, 1858-1860]. Abnormal overexpression of UCH-L1 has been shown to correlate with several forms of cancer [Hibi, K., et al. (1998) Cancer Res. 58, 5690-5694]. Because the amino acid sequence of UCH-L1 is similar to that of other ubiquitin C-terminal hydrolases, including the ubiquitously expressed UCH-L3, which appear to be unconnected to neurodegenerative disease, the structure of UCH-L1 and the effects of disease associated mutations on the structure and function are of considerable importance. We have determined the three-dimensional structure of human UCH-L1 at 2.4-A resolution by x-ray crystallography. The overall fold resembles that of other ubiquitin hydrolases, including UCH-L3, but there are a number of significant differences. In particular, the geometry of the catalytic residues in the active site of UCH-L1 is distorted in such a way that the hydrolytic activity would appear to be impossible without substrate induced conformational rearrangements.
==Disease==
==Disease==
Line 11: Line 10:
==About this Structure==
==About this Structure==
-
2ETL is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with CL as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2ETL OCA].
+
2ETL is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=CL:'>CL</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2ETL OCA].
==Reference==
==Reference==
Line 18: Line 17:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Das, C.]]
[[Category: Das, C.]]
-
[[Category: Hoang, Q.Q.]]
+
[[Category: Hoang, Q Q.]]
-
[[Category: Kreinbring, C.A.]]
+
[[Category: Kreinbring, C A.]]
-
[[Category: Lansbury, P.T.]]
+
[[Category: Lansbury, P T.]]
-
[[Category: Luchansky, S.J.]]
+
[[Category: Luchansky, S J.]]
-
[[Category: Meray, R.K.]]
+
[[Category: Meray, R K.]]
-
[[Category: Petsko, G.A.]]
+
[[Category: Petsko, G A.]]
-
[[Category: Ray, S.S.]]
+
[[Category: Ray, S S.]]
[[Category: Ringe, D.]]
[[Category: Ringe, D.]]
[[Category: CL]]
[[Category: CL]]
[[Category: deubiquitinating thiol hydrolase]]
[[Category: deubiquitinating thiol hydrolase]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 21:55:32 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:14:29 2008''

Revision as of 15:14, 21 February 2008


2etl, resolution 2.400Å

Drag the structure with the mouse to rotate

Crystal Structure of Ubiquitin Carboxy-terminal Hydrolase L1 (UCH-L1)

Contents

Overview

The ubiquitin C-terminal hydrolase UCH-L1 (PGP9.5) comprises >1% of total brain protein but is almost absent from other tissues [Wilkinson, K. D., et al. (1989) Science 246, 670-673]. Mutations in the UCH-L1 gene have been reported to be linked to susceptibility to and protection from Parkinson's disease [Leroy, E., et al. (1998) Nature 395, 451-452; Maraganore, D. M., et al. (1999) Neurology 53, 1858-1860]. Abnormal overexpression of UCH-L1 has been shown to correlate with several forms of cancer [Hibi, K., et al. (1998) Cancer Res. 58, 5690-5694]. Because the amino acid sequence of UCH-L1 is similar to that of other ubiquitin C-terminal hydrolases, including the ubiquitously expressed UCH-L3, which appear to be unconnected to neurodegenerative disease, the structure of UCH-L1 and the effects of disease associated mutations on the structure and function are of considerable importance. We have determined the three-dimensional structure of human UCH-L1 at 2.4-A resolution by x-ray crystallography. The overall fold resembles that of other ubiquitin hydrolases, including UCH-L3, but there are a number of significant differences. In particular, the geometry of the catalytic residues in the active site of UCH-L1 is distorted in such a way that the hydrolytic activity would appear to be impossible without substrate induced conformational rearrangements.

Disease

Known disease associated with this structure: Parkinson disease, familial OMIM:[191342]

About this Structure

2ETL is a Single protein structure of sequence from Homo sapiens with as ligand. Full crystallographic information is available from OCA.

Reference

Structural basis for conformational plasticity of the Parkinson's disease-associated ubiquitin hydrolase UCH-L1., Das C, Hoang QQ, Kreinbring CA, Luchansky SJ, Meray RK, Ray SS, Lansbury PT, Ringe D, Petsko GA, Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4675-80. Epub 2006 Mar 13. PMID:16537382

Page seeded by OCA on Thu Feb 21 17:14:29 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools